United Kingdom · Question · Written question
UIN 28232
Skin Diseases: Steroid Drugs
Original
Introduced
6 July 2021
Last action
28 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 July 2021
Summary
To ask the Secretary of State for Health and Social Care, whether his Department plans to modify the labelling of topical steroid medications to include clear warnings against over-use.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 July 2021
Written question
To ask the Secretary of State for Health and Social Care, whether his Department plans to modify the labelling of topical steroid medications to include clear warnings against over-use.
Source: Commons
28 July 2021
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) is conducting a review of topical steroid withdrawal. The review is discussing alterations to labelling, guidance and communications with health care professionals. We have consulted on these ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-06/28232
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1344069
- uk · wq-1344069 · source updated 28 July 2021